Cargando…
Cost–effectiveness of screening for active cases of tuberculosis in Flanders, Belgium
OBJECTIVE: To assess the cost–effectiveness of the tuberculosis screening activities currently funded by the Flemish government in Flanders, Belgium. METHODS: After estimating the expenses for 2013–2014 of each of nine screening components – which include high-risk groups, contacts and people who ar...
Autores principales: | Smit, G Suzanne A, Apers, Ludwig, Arrazola de Onate, Wouter, Beutels, Philippe, Dorny, Pierre, Forier, An-Marie, Janssens, Kristien, Macq, Jean, Mak, Ruud, Schol, Sandrina, Wildemeersch, Dirk, Speybroeck, Niko, Devleesschauwer, Brecht |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
World Health Organization
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5180339/ https://www.ncbi.nlm.nih.gov/pubmed/28053362 http://dx.doi.org/10.2471/BLT.16.169383 |
Ejemplares similares
-
The health and economic burden of haemophilia in Belgium: a rare, expensive and challenging disease
por: Henrard, Séverine, et al.
Publicado: (2014) -
Lyme borreliosis in Belgium: a cost-of-illness analysis
por: Geebelen, Laurence, et al.
Publicado: (2022) -
Quantifying burden of disease to support public health policy in Belgium: opportunities and constraints
por: Devleesschauwer, Brecht, et al.
Publicado: (2014) -
Acute hepatitis B notification rates in Flanders, Belgium, 2009 to 2017
por: Koc, Özgür, et al.
Publicado: (2019) -
Exploratory study of risk factors related to SARS-CoV-2 prevalence in nursing homes in Flanders (Belgium) during the first wave of the COVID-19 pandemic
por: Janssens, Heidi, et al.
Publicado: (2023)